Why it may matterVerify against the original reporting
Fundamental catalyst (GM award) plus technical bullish signals (100-day MA crossover, SVS volatility) and meaningful short interest create upside potential, despite a soft consensus target and overbought RSI.
AI summary
What happened, with direct paths to the underlying reporting
Cleveland-Cliffs (CLF) surged 7.2% to about $12.85 after being named GM’s Supplier of the Year for 2025, aided by higher steel prices. The stock has enjoyed a 24% weekly gain and a five-day win streak, with a bullish 100-day moving average crossover that historically preceded gains about 73% of the time. However, RSI near 70 and elevated short interest imply upside may be tempered by near-term overbought conditions.
CLF up 7.2% to $12.85; GM Supplier of the Year 2025 awarded earlier.
One-week gains of 24% and a five-day win streak rally the stock.
100-day MA crossover occurred 11 times in 10 years, with 73% higher in 1 month.
Short interest 4.61 million shares (~15% of float) could fuel a squeeze.
Analyst coverage mixed; 12 of 14 hold-or-worse with $10.86 median target.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Canada gave Cleveland-Cliffs 15 days to reverse planned job cuts at its Ontario steel mill, warning sanctions could include a forced divestiture. The move injects regulatory risk…
Cleveland-Cliffs posted a strong Q3, swinging to profit with revenue of $5.6 billion and EBITDA of $612 million, topping expectations. Higher steel sales and prices drove the beat…
Cleveland-Cliffs will report Q3 results on Oct 19 with an expected $0.24 per share on $5.72B revenue, a turn from last year’s loss. The $1B Middletown Works investment enhances ca…
Analysts highlighted Cleveland-Cliffs as a potential beneficiary after Jim Lebenthal endorsed the stock on CNBC’s Halftime Report Final Trades. JP Morgan maintained a Neutral rati…